Orphanet Journal of Rare Diseases (Mar 2024)

Patient-reported impact of symptoms in adrenoleukodystrophy (PRISM-ALD)

  • Anika Varma,
  • Jennifer Weinstein,
  • Jamison Seabury,
  • Spencer Rosero,
  • Nuran Dilek,
  • John Heatwole,
  • Charlotte Engebrecht,
  • Shaweta Khosa,
  • Kaitlin Chung,
  • Asif Paker,
  • Amy Woo,
  • Gregory Brooks,
  • Chan Beals,
  • Rohan Gandhi,
  • Chad Heatwole

DOI
https://doi.org/10.1186/s13023-024-03129-6
Journal volume & issue
Vol. 19, no. 1
pp. 1 – 22

Abstract

Read online

Abstract Background Adrenoleukodystrophy (ALD) is a multifaceted, X-linked, neurodegenerative disorder that comprises several clinical phenotypes. ALD affects patients through a variety of physical, emotional, social, and other disease-specific factors that collectively contribute to disease burden. To facilitate clinical care and research, it is important to identify which symptoms are most common and relevant to individuals with any subtype of ALD. Methods We conducted semi-structured qualitative interviews and an international cross-sectional study to determine the most prevalent and important symptoms of ALD. Our study included adult participants with a diagnosis of ALD who were recruited from national and international patient registries. Responses were categorized by age, sex, disease phenotype, functional status, and other demographic and clinical features. Results Seventeen individuals with ALD participated in qualitative interviews, providing 1709 direct quotes regarding their symptomatic burden. One hundred and nine individuals participated in the cross-sectional survey study, which inquired about 182 unique symptoms representing 24 distinct symptomatic themes. The symptomatic themes with the highest prevalence in the overall ALD sample cohort were problems with balance (90.9%), limitations with mobility or walking (87.3%), fatigue (86.4%), and leg weakness (86.4%). The symptomatic themes with the highest impact scores (on a 0–4 scale with 4 being the most severe) were trouble getting around (2.35), leg weakness (2.25), and problems with balance (2.21). A higher prevalence of symptomatic themes was associated with functional disability, employment disruption, and speech impairment. Conclusions There are many patient-relevant symptoms and themes that contribute to disease burden in individuals with ALD. These symptoms, identified by those having ALD, present key targets for further research and therapeutic development.

Keywords